AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
PDF (116.9 KB)
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Editorial | Open Access

PD-1 inhibitors provide new opportunities in conversion therapy for stage Ⅳ gastric cancer

Gastric Cancer Center, Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin’s Clinical Research Center for Cancer, Tianjin 300060, China
Show Author Information

References

【1】
【1】
 
 
Cancer Biology & Medicine
Pages 565-568

{{item.num}}

Comments on this article

Go to comment

< Back to all reports

Review Status: {{reviewData.commendedNum}} Commended , {{reviewData.revisionRequiredNum}} Revision Required , {{reviewData.notCommendedNum}} Not Commended Under Peer Review

Review Comment

Close
Close
Cite this article:
Liang H. PD-1 inhibitors provide new opportunities in conversion therapy for stage Ⅳ gastric cancer. Cancer Biology & Medicine, 2022, 19(5): 565-568. https://doi.org/10.20892/j.issn.2095-3941.2022.0244

584

Views

39

Downloads

4

Crossref

3

Web of Science

3

Scopus

Received: 16 May 2022
Accepted: 18 May 2022
Published: 24 June 2022
©2022 Cancer Biology & Medicine.

Creative Commons Attribution-NonCommercial 4.0 International License